Mitochondrial research · Metabolic questions
Explore the science before the promise.
MOTS-c has become a familiar name in discussions of metabolism and healthy aging. Scientific interest is real, but the step from laboratory research to a useful human treatment is substantial. Learn what FDA reviewed in 2026, where the evidence remains limited and how to separate a research hypothesis from a care option you can actually use.
Educational topic · This is not an offered treatment or trial-access program.
Research & evidence
Clear prices. A clearer next step.
Explore the research. Understand the price context.
The research-market figure below is educational context. Neither a free account nor optional membership purchases access to this compound.
Estimated research-market price · not a treatment offer
MOTS-C · research market context
Est. $116per 10 mg laboratory research vial
Single selected public supplier listing. This is research-market context, not a clinical drug quote, treatment cost or purchase offer.
Research-material market context only. Seine Bio does not sell lyophilized powders for self-reconstitution or offer this research compound. This figure does not price a finished clinical product; any lawful treatment requires its own quote. Membership does not provide the named investigational compound.
Discuss my care optionsPrice sources & what is included
Public research-material listings reviewed October 7, 2026. Prices and stock can change; taxes and shipping may be additional. These source links document laboratory listings, not patient-use products, supplier quality or lawful clinical availability.
Optional product-savings membership
Start with a personal care conversation.
$20Per month · Cancel anytime
- 2% off products; therapy services and membership dues excluded
- Free two-business-day shipping after dispatch on $100+ physical-product orders before discounts and taxes in the contiguous United States
- Cancel anytime to stop future membership renewals
Medication, labs, products and additional treatment cost extra. Care is subject to clinical fit and availability. Membership does not guarantee a prescription, named peptide or research enrollment.
Create a free account ↗The context behind the conversation
MOTS-c Research.
A clearer overview.
Research information is not treatment access.
Research education. No approved MOTS-c treatment or verified commercial supply pathway is offered.
The biological question.
MOTS-c is described in FDA’s evaluation as a sixteen-amino-acid peptide. Research examines biological processes that could be relevant to metabolic questions, but FDA notes that molecular targets and organ effects remain uncertain. A mechanism proposed in laboratory or rodent work does not predict a dependable benefit in people. Differences in material identity, manufacturing and formulation also matter when interpreting products marketed under one common name.
The story behind the name.
The MOTS-c compounding nomination was withdrawn, and FDA chose to evaluate the substance on its own initiative. The July 23–24, 2026 Pharmacy Compounding Advisory Committee considered the topic. FDA states that committee recommendations are nonbinding. Withdrawal from an interim category and advisory consideration should therefore not be described as drug approval or a final authorization to compound. No subsequent final authorization was verified for this page.
FDA’s July 2026 briefing evaluated proposed uses involving obesity and osteoporosis and reviewed laboratory and animal findings. It did not identify clinical studies evaluating administration of the nominated MOTS-c substances in humans. This is a major limit when discussing effectiveness, safety and an appropriate clinical use. A clinical-trial registry listing, if found elsewhere, is not itself a published result or authorization to offer a treatment. Approved alternatives for the nominated conditions already exist and deserve consideration in a real care conversation.
Understand the evidence
Understanding doses
and cycles.
A clear reference for your conversation with a clinician.
Research doses describe a specific study, not a treatment plan. Online popularity does not establish safety.
| Preparation / context | Dose reference | Frequency | Duration / cycle | Evidence & source |
|---|---|---|---|---|
| MOTS-c | Not established for this proposed wellness use | Not established | No validated human on/off cycle | Evidence limitations MOTS-c itself is distinct from analogues studied under other development names. Read the source |
Swipe or scroll sideways to see every column. There is no universal peptide cycle. A published trial, a product label and an informal online protocol are different kinds of information.
Sources reviewed October 7, 2026. A dose listed here does not establish availability or suitability through Seine Bio.
Discuss my optionsA useful conversation includes the limits
Know the concerns.
Understand the criteria.
These are key considerations, not a complete safety assessment.
Risks & uncertainties
What deserves attention.
- FDA identifies uncertainty about immune reactions, peptide-related impurities and characterization of the material.
- Human safety and clinical benefit were not established in the cited FDA evaluation.
- Animal findings may not translate to the same effects or safety in people.
- Online research labels and certificates do not establish a finished medicine suitable for patient care.
Clinical & regulatory context
Where this pathway fits.
- There is no ordinary patient qualification process for a MOTS-c program offered here.
- Research participation, where a legitimate study exists, belongs to the study team and its protocol.
- Compounding law and any future final status must be affirmatively checked before availability is claimed.
- A wellness consultation may address your actual energy or metabolic concerns through other appropriate options.
A thoughtful way forward
Learning is a useful first step.
Begin with your questions.
Read the FDA research evaluation without paying for access.
Understand the evidence.
Bring specific claims or research questions to a clinical discussion if useful.
Clarify your next step.
Explore established evaluation and treatment options for the symptoms you want to address.
Educational topic · This is not an offered treatment or trial-access program.
Create a free account ↗Clear answers before you decide
Your questions.
A clearer starting point.
Take a moment to understand the practical differences, limits and next steps.
Does MOTS-c have an FDA-approved use?
No approved drug component or applicable USP/NF drug-substance monograph was identified in FDA’s 2026 evaluation. This page is educational. It does not advertise a prescription or a purchasable treatment.
Did the July 2026 meeting make it legal to sell?
An advisory committee recommendation is nonbinding and differs from a final agency action. The reviewed nomination history does not establish a final compounding authorization. This page does not claim an available MOTS-c program.
Why mention animal studies if they do not prove benefit?
They help explain why researchers are interested. They can generate hypotheses and guide later work. The important distinction is that a biological signal in a model is not a demonstrated patient outcome or an established safety profile.
Can I still get help with fatigue or metabolic concerns?
You can seek an appropriate assessment of those concerns without expecting MOTS-c. A clinician can review symptoms, history and relevant findings. Education is free to read; membership should not be purchased on the assumption that an unverified intervention will become available.
Your next step, made simple
Bring your questions.
Find your next step.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
- Research questions and established care options
- Clear availability and costs before you decide
- Personal health history shared through private clinical intake
This is a consultation inquiry, not an order for this compound or a request for guaranteed research access. Clinical suitability and any separate costs are confirmed later.
Start with a free account.
Optional membership: $20/month.
Optional · $20/month · Cancel anytime. Medications, labs, products, additional therapy and separately priced treatments cost extra.
Create a free account to request review and manage purchases. Paid membership is optional. Clinical review and authorization still apply where required, and any separate service charges are shown before you agree to pay.
Please keep medical history, medications and sensitive personal details for private clinical intake.
Read beyond the headline
The sources.
Your own closer look.
Follow the original research, prescribing information and official regulatory sources used for this page.
Reviewed October 7, 2026. Evidence and regulatory status can change.
Your next step.Understand your options first.
Create a free accountIndividual care decisions belong to a licensed clinician. Program information does not guarantee a prescription, named compound, appointment, clinical-trial enrollment or product availability. Clinical care requires appropriate licensing, assessment and follow-up. Membership does not replace clinical eligibility.
We do not provide emergency services. For immediate danger or a medical emergency, call 911. For a mental health crisis in the U.S., call or text 988.
Lifestyle imagery is illustrative, not a patient testimonial.